1.
Relative bioavailability and bioequivalence of famciclovir tablets in healthy volunteers
泛昔洛韦片的人体相对生物利用度及生物等效性研究
2.
Preparation and in vitro release of Acyclovir Intragastric Floating Sustained Release Tablets
阿昔洛韦胃漂浮缓释片的制备及体外释放
3.
Pharmacokinetics and bioequivalence of valaciclovir hydrochloride tablets
盐酸伐昔洛韦片的人体药动学及生物等效性
4.
Evaluation of Uncertainty Measurement in the Content Determination of Valaclovir Hydrochloride Tablets by UV
盐酸伐昔洛韦片含量测定的不确定度评定
5.
Resonance light scattering spectrometric method for the determination of aciclovir in tablets
共振光散射光谱法测定片剂中阿昔洛韦的含量
6.
Simultaneous and Rapid Determination of Aciclovir, Ganciclovir and Penciclovir in Plasma Using Solid-phase Extraction and High-performance Liquid Chromatography;
SPE-HPLC法同时快速测定血浆中更昔洛韦、阿昔洛韦和喷昔洛韦的浓度
7.
CLINICAL OBSERVATION OF NARROW-BAND ULTRAVIOLET B PHOTOTHERAPY COMBINED WITH FAMCICLOVIR ON HERPES ZOSTER
窄谱中波紫外线联合泛昔洛韦治疗带状疱疹的临床观察
8.
Treatment of cephalosome and facial herpes zoster with famciclovir and acupuncture injection
泛昔洛韦联合穴位注射治疗头面部带状疱疹效果观察
9.
Studies on Determination of Plasma Concentration and Pharmacokinetics of Famciclovir Sustained Release Pellets in Dogs
泛昔洛韦缓释微丸体内测定方法的建立及药动学研究
10.
Comparison of Effects of Ganciclovir and Acyclovir on Adult Varicella
更昔洛韦和阿昔洛韦治疗成人水痘的疗效比较
11.
Method for determining ganciclovir quantity contained in ganciclovir cream
更昔洛韦乳膏中更昔洛韦含量测定方法的研究
12.
Therapeutic effects of ganciclovir and aciclovir on varicella
更昔洛韦与阿昔洛韦治疗水痘临床疗效分析
13.
Effect of peneiclovir cream on 164 genital herpes patients
左旋咪唑片联合喷昔洛韦乳膏治疗生殖器疱疹164例疗效观察
14.
Pharmacokinetics of acyclovir bioadhesive vaginal tablets in rats
阿昔洛韦生物黏附性阴道片在大鼠体内的药物动力学考察
15.
Rapid,Non-destructive Quantitative Determination of Acyclovir Tablets by NIR Combined with Partial Least Square
偏最小二乘法用于阿昔洛韦片的近红外漫反射快速、无损含量测定
16.
Bioequivalence Study of Ganciclovir Dispersible Tablet in Healthy Volunteers
更昔洛韦分散片在健康人体中的生物等效性研究
17.
A HPLC method was established for the determination of Aciclovir in Aciclovir urea cream.
建立阿昔洛韦尿素乳膏中阿昔洛韦含量的HPLC测定方法。
18.
In 153 cases of prevention research,88 were in GCV group and 65 in ACV group;
预防研究共153例，更昔洛韦组88例，阿昔洛韦组65例。